Stocks360

Albert Labs International Corp. (ABRT.CN)

Stock analysis · CNQ · Healthcare · Biotechnology

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
2.13
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

Albert Labs International Corp. (ABRT.CN) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Albert Labs International Corp.

Albert Labs International Corp. is a pharmaceutical research and development company dedicated to addressing urgent and underserved patient needs, particularly in critical mental health. The firm specializes in creating psilocybin-assisted therapies aimed at improving conditions such as anxiety, depression, and the psychological distress linked to cancer. This enterprise operates out of Burnaby, Canada.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap